AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Freshworks

SM Energy

Tellurian

Yamana Gold

Kinross Gold

Kohl's

NexTier Oilfield Solutions Inc

OPKO Health

Transocean

Southwestern Energy

Volume-weighted average price or VWAP is the ratio of total volume traded divided by the total volume traded for a chosen time frame. VWAP is an important indicator for intraday trading as it graphically tracks the average price of a stock, relative to the traded volume.

11 Stocks Moving Towards A VWAP Breakout: Tellurian, SM Energy, Freshworks And More

AdaptHealth Corp. (AHCO) CEO Steve Griggs on Q4 2021 Results - Earnings Call Transcript

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -62.50% and 1.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Q4 Earnings Miss Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)---- $AHCO--ADAPTHEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2021 RESULTS AND UPDATES 2022 GUIDANCE

AdaptHealth Reports Fourth Quarter and Full-Year 2021 Results and Updates 2022 Guidance

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)---- $AHCO--AdaptHealth to Participate in SVB Leerink 2022 Global Healthcare Conference

AdaptHealth to Participate in SVB Leerink 2022 Global Healthcare Conference

AdaptHealth Corp. (AHCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

AdaptHealth Corp. (AHCO) Moves 5.8% Higher: Will This Strength Last?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)---- $AHCO--ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND CONFERENCE CALL

AdaptHealth Corp. Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call

LeMaitre Vascular

AHCO vs. LMAT: Which Stock Is the Better Value Option?

AHCO vs. LMAT: Which Stock Should Value Investors Buy Now?

AdaptHealth Corp. (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AdaptHealth Corp. (AHCO) Upgraded to Buy: What Does It Mean for the Stock?

NEW YORK--(BUSINESS WIRE)-- #AHCO--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AdaptHealth Corp. (NASDAQ: AHCO) on behalf of long-term stockholders following a class action complaint that was filed against AdaptHealth on July 29, 2021. Our investigation concerns whether the board of directors of AdaptHealth have breached their fiduciary duties to the company. The complaint alleges that, throughout the Class Period, defe

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Is Investigating AdaptHealth Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)---- $AHCO--ADAPTHEALTH TO PARTICIPATE IN BofA SECURITIES HOME CARE CONFERENCE

AdaptHealth to Participate in BofA Securities Home Care Conference

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--ADAPTHEALTH TO PARTICIPATE IN BofA SECURITIES LEVERAGED FINANCE CONFERENCE

AdaptHealth to Participate in BofA Securities Leveraged Finance Conference

Stryker

AHCO vs. SYK: Which Stock Is the Better Value Option?

AHCO vs. SYK: Which Stock Should Value Investors Buy Now?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)---- $AHCO--AdaptHealth to Participate in Jefferies London Healthcare Conference

AdaptHealth to Participate in Jefferies London Healthcare Conference

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider AdaptHealth (AHCO).

Can AdaptHealth (AHCO) Stock Continue to Grow Earnings?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)---- $AHCO--ADAPTHEALTH TO PARTICIPATE IN STIFEL 2021 VIRTUAL HEALTHCARE CONFERENCE

AdaptHealth to Participate in Stifel 2021 Virtual Healthcare Conference

The mean of analysts' price targets for AdaptHealth Corp. (AHCO) points to a 60% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Does AdaptHealth Corp. (AHCO) Have the Potential to Rally 60% as Wall Street Analysts Expect?

AdaptHealth Corp. (AHCO) CEO Steve Griggs on Q3 2021 Results - Earnings Call Transcript

PetIQ

AHCO vs. PETQ: Which Stock Is the Better Value Option?

AHCO or PETQ: Which Is the Better Value Stock Right Now?

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -41.18% and 2.52%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Q3 Earnings Miss Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or “the Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2021. Highlights AdaptHealth delivered record net revenue and Adjusted EBITDA for the third quarter and further increased fiscal 2021 guidance, despite the challeng

AdaptHealth Announces Third Quarter 2021 Financial Results, Raises Full-Year 2021 Guidance, and Provides Full-Year 2022 Guidance

SAN DIEGO, Oct. 20, 2021 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of AdaptHealth Corp ("AdaptHealth" or the "Company") (NASDAQ: AHCO) against certain of its officers and directors.  Recently a class action lawsuit was filed in federal court against the Company on behalf of purchasers of the securities of AdaptHealth from November 11, 2019 and July 16, 2021 (the "Class Period").

(AHCO) Alert: Did You Acquire Adapt Health Before November 11, 2019? Should Management be Held Accountable for Investors Losses?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2021 financial results before the opening of the financial markets on Thursday, November 4, 2021. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analy

AdaptHealth Corp. Announces Earnings Release Date and Conference Call

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Greg Belinfanti was appointed to the Company's Board of Directors. Mr. Belinfanti is a Senior Managing Director of One Equity Partners and will serve as OEP's designee on the Board of Directors. Mr. Belinfanti currently

AdaptHealth Corp. Announces Appointment of Greg Belinfanti as Director

New York, New York--(Newsfile Corp. - September 27, 2021) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (NASDAQ: AHCO) alleging that the Company violated federal securities laws.Class Period: November 11, 2019 and July 16, 2021Lead Plaintiff Deadline: September 27, 2021No obligation or cost to you.Learn more about your recoverable losses in AHCO:https://www.kleinstocklaw.com/pslra-1/adapthealth-corp-f-k-a-dfb-healthcare-acquisitions-corp-loss-submission-form?id=199

AHCO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 27, 2021 in the Class Action Filed on Behalf of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. Limited Shareholders

News for AdaptHealth Corp Stock (AHCO)